M
Martin Buxton
Researcher at Brunel University London
Publications - 86
Citations - 7953
Martin Buxton is an academic researcher from Brunel University London. The author has contributed to research in topics: Cost effectiveness & Economic evaluation. The author has an hindex of 37, co-authored 86 publications receiving 7551 citations. Previous affiliations of Martin Buxton include Papworth Hospital & University of the West.
Papers
More filters
Journal Article
Evaluating patient-based outcome measures for use in clinical trials.
TL;DR: This research highlights the need to understand more fully the rationale behind the continued use of these devices, as well as the barriers to their adoption.
Journal ArticleDOI
Evaluating patient-based outcome measures for use in clinical trials: a review
Journal ArticleDOI
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
Scott D. Ramsey,Richard J. Willke,Andrew Briggs,Ruth E. Brown,Martin Buxton,Anita Chawla,John R. Cook,Henry A. Glick,Bengt Liljas,Diana B. Petitti,Shelby D. Reed +10 more
TL;DR: Trial-based cost-effectiveness studies have appeal because of their high internal validity and timeliness and improving the quality and uniformity of these studies will increase their value to decision makers who consider evidence of economic value along with clinical efficacy when making resource allocation decisions.
Journal ArticleDOI
Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis
TL;DR: The types of uncertainty that exist in economic evaluation are reviewed and it is argued that some forms of uncertainty are not amenable to statistical methods.
Journal ArticleDOI
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
Karl Claxton,Mark Sculpher,Christopher McCabe,Andrew Briggs,Ron Akehurst,Martin Buxton,John Brazier,Tony O'Hagan +7 more
TL;DR: The NICE guidance on dealing with uncertainty is placed into a broader context of the requirements for decision making; the general approach that was taken in its development is explained; and each of the issues which have been raised in the debate about the role of probabilistic sensitivity analysis in general are addressed.